The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients

Rev Assoc Med Bras (1992). 2022 Aug;68(8):979-981. doi: 10.1590/1806-9282.20220643.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Contrast Media / adverse effects
  • Drug-Related Side Effects and Adverse Reactions*
  • Gadolinium / adverse effects
  • Humans
  • Magnetic Resonance Imaging / adverse effects
  • Multiple Sclerosis* / chemically induced
  • Multiple Sclerosis* / diagnostic imaging
  • Multiple Sclerosis* / drug therapy

Substances

  • Contrast Media
  • Gadolinium